Remove 2026 Remove Marketing Remove Pharma Companies Remove Vaccine
article thumbnail

Changes to UK Statutory Scheme go ahead despite pharma criticism

Drug Discovery World

It intends to set amended payment percentages for 2024 to 2026 based on an allowed growth rate that has been increased to 2%. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8% While the published rates are down on the record 27.5%

article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . The global lab automation market for drug discovery is expected to grow by a CAGR of 5% between 2021 – 2026, according to a report by Mordor Intelligence. . Cell and gene therapies.

Drugs 130